Journals / Solunum / 2007 / Cilt: 9 - Sayı: 1

Management of malign pleural effusion

Malign plevral efüzyonda yaklaşım

Journal
Solunum
Pages
37–42
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, approach to diagnosis of malign pleural effusion is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Malign pleural effusion is a common clinical problem because of difficulties in diagnosis and treatment.
📊
Key Findings & Data:Lung cancer including malign mesothelioma is the most cause of malign pleural effusion however, all form of cancer including cancer of breast, ovary, stomach, lymphoma may cause malign pleural effusion.
💡
Conclusion & Impact:In this review, approach to diagnosis of malign pleural effusion is presented.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Plevral efüzyon · malign · Biyopsi

Abstract

Malign pleural effusion is a common clinical problem because of difficulties in diagnosis and treatment. Lung cancer including malign mesothelioma is the most cause of malign pleural effusion however, all form of cancer including cancer of breast, ovary, stomach, lymphoma may cause malign pleural effusion. The diagnosis of malign pleural effusion requires either histological or cytological demonstration of malignant cells in the pleural tissue or pleural fluid. Median survival is dependent on the stage and type of the underlying malignancy. Many pleural fluid tests and invasive procedure are useful in differential diagnosis of malign effusions. In this review, approach to diagnosis of malign pleural effusion is presented.

Özet

Malign plevral efüzyonlar tanı ve tedavi yönünden yaygın bir klinik problemdir. Mezotelyomayı da içeren akciğer kanserleri malign efüzyonların en sık nedeni olsa da meme, over, mide kanseri-ve lenfomanın bütün formları da malign plevral efüzyona neden olabilir. Malign plevral efüzyon tanısı için hem histolojik hem de sitolojik malign hücrelerin plevra sıvısı veya dokuda gösterilmesi gerekir. Ortalama yaşam süresi altta yatan hastalığın tipine ve evresine bağlıdır. Malign plevral efüzyonların ayrıcı tanısında birçok sıvı testleri ve invazif işlemler yararlıdır. Bu yazıda, malign plevral efüzyonlara tanı yaklaşımı sunulmuştur.

🔖

Cite This Article

ARINÇ, S. (2007). Management of malign pleural effusion. Solunum, Cilt: 9 - Sayı: 1, 37–42. https://ajindex.com/articles/314418

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Black LF. The pleural space and pleural fluid. Mayo Clin Proc 1972; 47:493-506
  2. Light R.PIeural effusions. Med Clin North Am 1977; 61:1339-52
  3. Stewart PB. The rate of formation and lymphatic removal of fluid in pleural effusion. J Clin Invest 1963;42: 258-62
  4. Decamp MM, Mentzer SJ, Swanson SJ, Sugarbaker DJ. Malign effusive Disease of the pleura and pericardium. Chest 1997; 112:291-5 5. Âleman CAIegra J, Segura RM, et al. Polymorphonuclear elastase in early diagnosis of complicated pyogenic pleural effusion. Respiration 2003;70:462-7
  5. Ruckdeschel JC. Managment of malign pleural effusion. Semin Oncol 1988; 5: 24-8
  6. Lee YCG, DeKlerk NH, Henderson DW, Musk AW. Malign mesothelioma. In: Hendrick DJ, Burge PS, Beckett WS, Churg A, eds. Occupational disorder of the lung. Recognition, managment and prevention. London: WB Saunders; 2002;359-79
  7. Lee YCG, Dean A, Thompson Rl, Robinson BWS. Robinson BWS, Chahinian P. Mesothelioma. London: Martin Dunitz; 2002; 111-26
  8. Boutin C, Rey F. Thoracoscopy in pleural malignant •mesothelioma. A prospective study of 188 consecutive patients. Parti: Diagnosis. Cancer 1993;72:389-93
  9. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977; 63: 695-702
  10. American Thoracic Society. Managment of malignant pleural effusions. Am J Resp Grit Care Med 2000; 162:1987-2001. 12.Tammilehto L, Maasilita P, Kostianen S, et al. Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty five patients. Respiration 1992;52:129-35
  11. AntonyVB, LoddenkemperR,Astoul P, etal. Management of malignant pleural effusions. Eur Respir J 2001; 18: 402-19
  12. Bernard F, Stermen D, Smith RJ, et al. Metabolic imaging of malign pleural mesothelioma with flurodeoxyglucose positron emission tomography. Chest 1998; 144: 713-22
  13. Lee YCG, Davies RJO. Management of pleural effusions in acute medical settings: a practical guide. CPD J Acute Med 2004;3:26-32
  14. Johnston WW, The malignant pleural effusion: a review of cytopathological diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985;56: 905-9
  15. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5255 samples from 3811 patients. Diag Cytopathol 1987; 3: 8-12
  16. Starr RL, Sherman ME. The value of multiple preparations in diagnosis of malignant pleural effusions. Acta Cytol 1991; 35: 533-7
  17. Loddenkemper R, Grosser H, Gabler A et al. Prospective